IN2015DN01616A - - Google Patents

Download PDF

Info

Publication number
IN2015DN01616A
IN2015DN01616A IN1616DEN2015A IN2015DN01616A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A IN 1616DEN2015 A IN1616DEN2015 A IN 1616DEN2015A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A
Authority
IN
India
Prior art keywords
tissue
cells
cell formulation
myocardial
pluripotent stem
Prior art date
Application number
Other languages
English (en)
Inventor
Masanori Yoshida
Shinya Minatoguchi
Mari Dezawa
Original Assignee
Clio Inc
Univ Gifu
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clio Inc, Univ Gifu, Univ Tohoku filed Critical Clio Inc
Publication of IN2015DN01616A publication Critical patent/IN2015DN01616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
IN1616DEN2015 2012-08-17 2013-08-15 IN2015DN01616A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012181029 2012-08-17
PCT/JP2013/054049 WO2014027474A1 (ja) 2012-08-17 2013-02-19 心筋梗塞の修復再生を誘導する多能性幹細胞
PCT/JP2013/071981 WO2014027684A1 (ja) 2012-08-17 2013-08-15 心筋梗塞の修復再生を誘導する多能性幹細胞

Publications (1)

Publication Number Publication Date
IN2015DN01616A true IN2015DN01616A (enExample) 2015-07-03

Family

ID=50685515

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1616DEN2015 IN2015DN01616A (enExample) 2012-08-17 2013-08-15

Country Status (14)

Country Link
US (3) US9844570B2 (enExample)
EP (2) EP2886123B1 (enExample)
JP (1) JP5968442B2 (enExample)
KR (1) KR101730052B1 (enExample)
CN (1) CN104582711B (enExample)
AU (1) AU2013303492B2 (enExample)
CA (1) CA2882239C (enExample)
DK (1) DK2886123T3 (enExample)
ES (1) ES2767182T3 (enExample)
IN (1) IN2015DN01616A (enExample)
PL (1) PL2886123T3 (enExample)
PT (1) PT2886123T (enExample)
SG (2) SG10201800829XA (enExample)
WO (2) WO2014027474A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
JP2015160820A (ja) * 2014-02-26 2015-09-07 株式会社Ｃｌｉｏ 慢性腎障害治療のための多能性幹細胞
JP6452107B2 (ja) * 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
JP6770673B2 (ja) * 2016-02-26 2020-10-21 国立大学法人東海国立大学機構 急性心筋梗塞の予後マーカー及びその利用
US20190201455A1 (en) * 2016-07-01 2019-07-04 Tohoku University Prophylactic or therapeutic agent for organ fibrosis
WO2018021515A1 (ja) * 2016-07-29 2018-02-01 国立大学法人東北大学 血管障害の予防又は治療剤
WO2018025973A1 (ja) * 2016-08-03 2018-02-08 国立大学法人名古屋大学 多能性幹細胞による慢性肺疾患の改善及び治療
JP7148402B2 (ja) 2016-08-03 2022-10-05 株式会社生命科学インスティテュート インビトロで多能性幹細胞を分化誘導する方法
AU2017305067B2 (en) * 2016-08-03 2022-11-03 Hiroshi Yabuki Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
CN106822899B (zh) * 2017-03-10 2020-11-27 北京大学 一种通过抑制自噬促进心肌再生的药物
EP3698802A4 (en) * 2017-10-17 2021-05-26 Hiroshima University Pluripotent stem cells inducing osteochondral repair
JP7102666B2 (ja) * 2018-01-25 2022-07-20 国立大学法人東海国立大学機構 Ｍｕｓｅ細胞動員剤及び心筋障害への利用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN110302212A (zh) * 2019-07-17 2019-10-08 陶正博 一种用于治疗急性心肌梗死的细胞制剂及其制备方法
US12460182B2 (en) 2019-08-19 2025-11-04 Cellaxia Inc. Cell-containing pharmaceutical composition
EP4026551A1 (en) * 2019-09-05 2022-07-13 Tohoku University Therapeutic agent for myocarditis
EP4052718A1 (en) * 2019-10-31 2022-09-07 Life Science Institute, Inc. Therapy for interstitial cystitis by pluripotent stem cells
CA3179498A1 (en) 2020-04-02 2021-10-07 Tohoku University High-potential pluripotent stem cells
TWI825446B (zh) * 2020-08-14 2023-12-11 中國醫藥大學 醫藥組合物治療組織缺血狀況之用途
JP2021073305A (ja) * 2021-02-09 2021-05-13 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN119198334A (zh) * 2024-10-31 2024-12-27 北京大学深圳研究生院 一种心肌梗死边界区组织鉴定方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4543193A (en) * 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
DK1007631T4 (da) * 1997-07-14 2009-04-27 Osiris Therapeutics Inc Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller
AU5545499A (en) * 1998-07-31 2000-02-21 Genzyme Corporation Improvement of cardiac function by mesenchymal stem cell transplantation
US20020098167A1 (en) 2000-07-31 2002-07-25 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002057430A2 (en) * 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
IL159580A0 (en) 2001-07-12 2004-06-01 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US9782439B2 (en) 2005-01-27 2017-10-10 Japan Health Sciences Foundation Cell sheet containing mesenchymal stem cells
KR101420740B1 (ko) 2005-12-13 2014-07-17 교또 다이가꾸 핵초기화 인자
CN101517069A (zh) * 2006-07-13 2009-08-26 塞拉帝思股份公司 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群
WO2009046058A1 (en) 2007-10-01 2009-04-09 University Of Miami A method to amplify cardiac stem cells in vitro and in vivo
JP5394932B2 (ja) 2007-11-02 2014-01-22 日本ケミカルリサーチ株式会社 ヒト間葉系幹細胞含有医薬組成物
JP5564679B2 (ja) 2009-04-16 2014-07-30 公益財団法人ヒューマンサイエンス振興財団 心筋細胞分化誘導促進剤およびその使用方法
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
WO2012054501A1 (en) * 2010-10-18 2012-04-26 Sunshine Biotech Inc. Human multipotent embryonic stem cell-like progenitor cells
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞

Also Published As

Publication number Publication date
CN104582711A (zh) 2015-04-29
EP2886123B1 (en) 2019-10-23
EP3659612A1 (en) 2020-06-03
US10376544B2 (en) 2019-08-13
EP2886123A4 (en) 2016-06-22
AU2013303492B2 (en) 2017-02-16
JPWO2014027684A1 (ja) 2016-07-28
CA2882239A1 (en) 2014-02-20
SG10201800829XA (en) 2018-03-28
EP3659612B1 (en) 2023-06-07
WO2014027684A1 (ja) 2014-02-20
KR20150043482A (ko) 2015-04-22
PT2886123T (pt) 2020-01-22
CA2882239C (en) 2018-05-22
ES2767182T3 (es) 2020-06-16
US20150196600A1 (en) 2015-07-16
US9844570B2 (en) 2017-12-19
DK2886123T3 (da) 2020-01-27
SG11201501185WA (en) 2015-05-28
US20190307806A1 (en) 2019-10-10
KR101730052B1 (ko) 2017-04-25
US20180050067A1 (en) 2018-02-22
JP5968442B2 (ja) 2016-08-10
PL2886123T3 (pl) 2020-05-18
AU2013303492A1 (en) 2015-03-12
CN104582711B (zh) 2019-12-06
US10639335B2 (en) 2020-05-05
WO2014027474A1 (ja) 2014-02-20
EP2886123A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
IN2015DN01616A (enExample)
Baron et al. Mesenchymal stromal cells: a new tool against graft-versus-host disease?
Dong et al. Adipose stem cells in tissue regeneration and repair: From bench to bedside
Forostyak et al. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications
Kim et al. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance
NZ623454A (en) Pharmaceutical composition for the treatment of heart diseases
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
BR112014010776A8 (pt) neurônios dopaminérgicos (da) mesencefálicos para enxerto
MX340275B (es) Metodos, sistema y aparato para la deteccion, diagnostico y tratamiento de trastornos del ritmo biologico.
EP3825419A3 (en) Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
MX2013002381A (es) Celulas precursoras cd27 1 derivadas de medula osea para reparacion cardiaca.
CA2904533C (en) Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
EP2593115A4 (en) Treatment of t-cell mediated immune disorders
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
WO2014072720A3 (en) Cell differentiation
SG11201810188VA (en) Amelioration and treatment of perinatal brain damage with pluripotent stem cells
WO2012169897A8 (en) Weight reducing material
WO2012050829A3 (en) Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
Gui-xian et al. Therapeutic Effects of Umbilical Cord Mesenchymal Stem Cells Transplantation on Systemic Lupus Erythematosus
MY203762A (en) A biological conduit for promoting recovery of an injured nerve
CN202027610U (zh) 小肿瘤标本收集器
Wang et al. Study on the Efficacy and Safety of Transradial Approach for Primary Coronary Angioplasty in Acute Myocardial Infarction with Power Antithrombotic Therapy
Karataeva et al. THE MONITORING ORGANIZATION OF THE INDIVIDUAL REHABILITATION PROGRAMS IMPLEMENTATION EFFECTIVENESS IN NIZHNY NOVGOROD REGION